Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Research article

An association between time-varying serum albumin level and the mortality rate in maintenance haemodialysis patients: a five-year clinical cohort study

Authors: Jin-Bor Chen, Ben-Chung Cheng, Cheng-Hong Yang, Moi-Sin Hua

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Until now, no long-term studies relating serum albumin level to mortality rate in prevalent haemodialysis (HD) patients have been conducted. We aimed to examine the association between serum albumin level and mortality over a 5-year period.

Methods

This study included 781 patients who received maintenance HD in a large, hospital-facilitated HD centre. Five-year medical records (2009–2013) were retrospectively reviewed, and the cut-off level for serum albumin level was set at 3.5 g/dL. The analysed albumin levels were expressed as time-averaged levels (first 24-month data) and albumin target reach rate over the first 2-year interval. Univariate and multivariate Cox proportional hazard regression models were used to examine the hazard function of the all-cause and cardiovascular mortality of the study participants in the subsequent 3-year period (2011–2013).

Results

Compared to those with a 100 % albumin reach rate (3.5 g/dL), the participants with 75– < 100, 50– < 75, and 1– < 50 % albumin reach rates exhibited significantly increased risk for all-cause mortality (HR 1.72, 95 % CI 1.19–2.47; HR 3.14, 95 % CI 1.91–5.16; HR 3.66, 95 % CI 2.18–6.16, respectively). A similar trend for all-cause mortality was demonstrated in participants with time-averaged albumin levels <4 g/dL (HR 1.57, 95 % CI 1.00–2.46 for 3.5–4.0 g/dL; HR 3.66, 95 % CI 2.11–6.32 for <3.5 g/dL). Compared to a 100 % albumin reach rate, the 50– < 75 and 1– < 50 % groups (HR 4.28, 95 % CI 1.82–10.01; HR 3.23, 95 % CI 1.22–8.54 respectively) showed significantly higher cardiovascular mortality rates. Similarly, participants with a time-averaged serum albumin level <3.5 g/dL exhibited a higher risk for cardiovascular mortality (HR 3.24, 95 % CI: 1.23–8.56).

Conclusions

This long-term study demonstrated that higher reach rates of serum albumin levels and higher time-averaged serum albumin levels are associated with a lower mortality rate in patients undergoing maintenance HD.
Literature
1.
go back to reference Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993;44:115–9.CrossRefPubMed Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993;44:115–9.CrossRefPubMed
2.
go back to reference Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcom Jr H, Kopple JD, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005;20:1880–8.CrossRefPubMed Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcom Jr H, Kopple JD, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005;20:1880–8.CrossRefPubMed
3.
go back to reference Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol. 2008;3:759–67.CrossRefPubMedPubMedCentral Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol. 2008;3:759–67.CrossRefPubMedPubMedCentral
4.
go back to reference de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19:127–35.CrossRefPubMed de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19:127–35.CrossRefPubMed
5.
go back to reference Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. 1998;32:S118–25.CrossRefPubMed Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. 1998;32:S118–25.CrossRefPubMed
6.
go back to reference Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432–7.CrossRefPubMed Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432–7.CrossRefPubMed
7.
go back to reference Churchill DN, Taylor DW, Cook RJ, Laplante P, Barre P, Cartler P, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.CrossRefPubMed Churchill DN, Taylor DW, Cook RJ, Laplante P, Barre P, Cartler P, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.CrossRefPubMed
8.
go back to reference Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997;29:658–68.CrossRefPubMed Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997;29:658–68.CrossRefPubMed
9.
go back to reference Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–6.CrossRefPubMed Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–6.CrossRefPubMed
10.
go back to reference Chan M, Kelly J, Batterham M, Tapsell L. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study. J Ren Nutr. 2012;22:547.CrossRefPubMed Chan M, Kelly J, Batterham M, Tapsell L. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study. J Ren Nutr. 2012;22:547.CrossRefPubMed
11.
go back to reference Steiber AL. Clinical indicators associated with poor oral intake of patients with chronic renal failure. J Ren Nutr. 1999;9:8488.CrossRef Steiber AL. Clinical indicators associated with poor oral intake of patients with chronic renal failure. J Ren Nutr. 1999;9:8488.CrossRef
12.
go back to reference Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs. 1989;12:411–9.PubMed Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs. 1989;12:411–9.PubMed
13.
go back to reference Combe C, Chauveau P, Laville M, Fouque D, Azar R, Cano N, et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis. 2001;37:S81–8.CrossRefPubMed Combe C, Chauveau P, Laville M, Fouque D, Azar R, Cano N, et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis. 2001;37:S81–8.CrossRefPubMed
Metadata
Title
An association between time-varying serum albumin level and the mortality rate in maintenance haemodialysis patients: a five-year clinical cohort study
Authors
Jin-Bor Chen
Ben-Chung Cheng
Cheng-Hong Yang
Moi-Sin Hua
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0332-5

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.